Carl Zeiss Meditec AG
Company Profile
Business description
Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
Contact
Goschwitzer Strasse 51-52
JenaTH07745
DEUT: +49 3641220115
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 September 2025
Employees
5,713
Stocks News & Analysis
stocks
ResMed earnings: Solid showing from ASX healthcare winner
stocks
Is this the $80 billion elephant Warren Buffett has been waiting for?
stocks
Tesla: Board announces new pay package for CEO Elon Musk
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,028.80 | 106.80 | 1.20% |
CAC 40 | 7,632.01 | 85.85 | 1.14% |
DAX 40 | 23,757.69 | 331.72 | 1.42% |
Dow JONES (US) | 44,173.64 | 585.06 | 1.34% |
FTSE 100 | 9,128.30 | 59.72 | 0.66% |
HKSE | 24,911.97 | 178.52 | 0.72% |
NASDAQ | 21,053.58 | 403.45 | 1.95% |
Nikkei 225 | 40,549.54 | 258.84 | 0.64% |
NZX 50 Index | 12,877.04 | 193.00 | 1.52% |
S&P 500 | 6,329.94 | 91.93 | 1.47% |
S&P/ASX 200 | 8,770.40 | 106.70 | 1.23% |
SSE Composite Index | 3,614.24 | 30.93 | 0.86% |